Vanderbilt One Hundre Oaks — Nashville, Tennessee

Vanderbilt One Hundre Oaks is a clinical research site located in Nashville, Tennessee, United States 37204.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt One Hundre Oaks has participated in 1 clinical trials.

Therapeutic areas: Hormone-sensitive Metastatic Breast Cancer.

Sponsors: Vanderbilt-Ingram Cancer Center.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt One Hundre Oaks?

Vanderbilt One Hundre Oaks has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt One Hundre Oaks conducted?

Vanderbilt One Hundre Oaks has 1 clinical trials on record. Their work covers Hormone-sensitive Metastatic Breast Cancer.

Is Vanderbilt One Hundre Oaks accredited by Crixeo Health?

Vanderbilt One Hundre Oaks has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt One Hundre Oaks?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.